glp 1 and hs GLP-1 Medications – Community Education JDD Buzz Series | GLP-1

Alo Board Certified Internal Medicine Board Certified Cardiovascular Medicine Fellow of the American College of Cardiology Obesity & Weight Loss Medicine NASM Certified Personal Trainer Assistant Clinical Professor of Medicine, Midwestern University, Chicago, Illinois Assistant Clinical Professor of Medicine, Ohio University, Athens, Ohio PS: Can't wait to see you on the other side

If tirzepatide can reduce intracranial pressure enough to resolve headaches in IIH, it is plausible that it can reduce pressure enough to lower the migraine threshold in people without a formal IIH diagnosis

Joel Habener Massachusetts General Hospital Lotte Bjerre Knudsen Novo Nordisk Svetlana Mojsov The Rockefeller University For the discovery and development of GLP-1-based drugs that have revolutionized the treatment of obesity The 2024 Lasker~DeBakey Clinical Medical Research Award honors three scientists for their discovery and development of GLP-1-based drugs that have revolutionized the treatment of obesity

Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): A substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial